Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis

Phase 2 Completed 1000 enrolled Federal University of Pernambuco

NaSingle-groupOpen-labelPrevention

Summary

The aim of this study was to evaluate the efficacy and safety of the prophylactic effect of intracameral moxifloxacin for prevention of postcataract endophthalmitis.

Timeline

Start: 2013-01
Primary completion: 2018-06-20
Completion: 2018-06-20

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Moxifloxacin	Small molecule	—	Other

Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis

Summary

Timeline

Drugs

Indications